ICP Parking Lot/Vaccines
The issue
Bibliography
American Society of Law, Medicine & Ethics, Inc., and Boston University American Journal of Law & Medicine, 2009, 35 Am. J. L. and Med.:
p. 247, Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law, Kevin Outterson
p. 253, University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know-How in University Technology Transfer Policy, Sara E. Crager, Ethan Guillen, & Matt Price
p. 281, The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level, Beirne Roose-Snyder & Megan K. Doyle
p. 311, New Vaccines for Developing Countries: Will it be Feast or Famine?, Jon Kim Andrus, MD, + Ciro de Quadros, MD, MPH, Cuauhtemoc Ruiz Matus, MD, MPH, Silvana Luciani MHSc, & Peter Hotez, MD, PhD
p. 323, Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?, Peter Maybardule & Sarah Rimmingto
p. 351, Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine, Abigail English, Carol A. Ford, & John S. Santelli
p. 365, Human Rights In Health Equity: Cervical Cancer and HPV Vaccines, Joanna N. Erdman
p. 389, Potential Barriers to HPV Immunization: From Public Health to Personal Choice, Gregory D. Zimet
p. 401, 7040 words, ARTICLE: Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income Countries, Vivien Davis Tsu
p. 415, Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World, Sean McElligott
Follow-On Biologics: Intellectual Property and Innovation Issues introduces innovation policy issues pertaining to follow-on biologics. @http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
Emerging Health Care Issues: Follow-on Biologic Drug Competition @www.ftc.gov/os/2009/06/P083901biologicsreport.pdf